Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (including mixed tocopherols and tocotrienols) has been studied for its potential role in supporting eye health and preventing or slowing the progression of age-related macular degeneration (AMD). The primary scientific basis stems from its function as an antioxidant, which theoretically could protect retinal cells from oxidative damage—a factor implicated in AMD pathogenesis. The most notable study addressing this question is the Age-Related Eye Disease Study (AREDS) and its follow-up, AREDS2, which examined the effects of antioxidant supplements (including vitamin E, vitamin C, beta-carotene, zinc, and copper) on AMD progression. These studies found that the AREDS formula, which included 400 IU of vitamin E daily, modestly reduced the risk of progression to advanced AMD in people at high risk. However, the evidence does not support a benefit from vitamin E alone, nor does it indicate that vitamin E in mixed tocopherols or tocotrienols is superior to standard alpha-tocopherol. Subsequent studies and meta-analyses have not demonstrated a strong benefit of vitamin E supplementation alone for AMD prevention or treatment. Thus, while vitamin E is included as part of a broader antioxidant regimen with some scientific backing, its individual contribution is uncertain and not strongly supported by high-level evidence. Current clinical guidelines recommend the AREDS/AREDS2 formulations for certain patients with intermediate or advanced AMD, but not vitamin E supplementation alone.

More about Vitamin E (Mixed Tocopherols and Tocotrienols)
More about Macular Degeneration

Other ingredients used for Macular Degeneration

Other health conditions supported by Vitamin E (Mixed Tocopherols and Tocotrienols)

Products containing Vitamin E (Mixed Tocopherols and Tocotrienols)